{"id":"W4399799341","doi":"10.1007/s11523-024-01076-7","title":"Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical Trial","year":2024,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Karyopharm Therapeutics","keywords":"Medicine; Tolerability; Nausea; Adverse effect; Internal medicine; Clinical endpoint; Phases of clinical research; Vomiting; Clinical trial; Toxicity; Anorexia; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002092725,0.001063425,0.00151952,0.0003374867,0.0002819408,0.0009695136,0.0004984983,0.0008213691,0.003441703],"category_scores_gemma":[0.001175998,0.0002722068,0.001279084,0.0002343496,0.0009562502,0.001233534,0.0003171158,0.00262598,0.0009634037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004897549,"about_ca_system_score_gemma":0.0006360229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003410345,"about_ca_topic_score_gemma":0.0009007427,"domain_scores_codex":[0.9995161,0.000253466,0.00002301394,0.00006764753,0.00005405318,0.00008564181],"domain_scores_gemma":[0.9992068,0.0002350669,0.0001504834,0.0001005203,0.0000430794,0.0002640298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6599231,0.04303497,0.0085909,0.0009171761,0.001977073,0.0002840063,0.0003214198,0.006588457,0.0538671,0.0006933106,0.006223918,0.2175786],"study_design_scores_gemma":[0.3350754,0.6124582,0.03242005,0.00007263977,0.0008184687,0.0005390579,0.0002049281,0.003646014,0.009865596,0.0009699768,0.003861248,0.00006841318],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946727,0.001314798,0.0004248409,0.0004498631,0.00006564723,0.0003478708,0.0008262234,0.00009322356,0.001804846],"genre_scores_gemma":[0.9931998,0.001039073,0.0006362412,0.0005193646,0.00006657498,0.00039761,0.001709514,0.00004017323,0.00239179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003441703,"threshold_uncertainty_score":0.01151359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06135130984307056,"score_gpt":0.4211663489886444,"score_spread":0.3598150391455738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}